Dr. Ricardo Correa breaks down acromegaly—from subtle early signs and delayed diagnosis to treatment strategies and new meds.

Learn about Acromegaly disease, its symptoms like enlarged hands and facial features, and explore effective Acromegaly ...

Imagine living with unexplained changes and health issues for nearly a decade, only to discover it's a rare disease that was, until recently, very difficult to treat and can affect nearly every aspect ...

The journal Pituitary has highlighted research led by Manel Puig, head of the Endocrine, Thyroid and Obesity Research Group ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved paltusotine for first-line treatment of patients with acromegaly who did not respond to or ...

Credit: Crinetics. Palsonify is supplied as a 20mg and 30mg tablet. Palsonify is an oral, selectively-targeted somatostatin receptor type 2 nonpeptide agonist. The Food and Drug Administration (FDA) ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Crinetics Pharmaceuticals won Food and Drug Administration approval on ...

Sept 25 (Reuters) - The U.S. Food and Drug Administration approved Crinetics Pharmaceuticals' (CRNX.O), opens new tab drug to treat a rare hormonal disorder on Thursday, making it the first once-daily ...